Akebia Therapeutics, Inc. (AKBA)

CIK 1517022 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Akebia Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 10, 202640001591467-26-000004
Aug 5, 2026S-80001193125-26-335375
Aug 5, 202610-Q0001517022-26-000051
Aug 5, 20268-K0001517022-26-000050
Jul 1, 202640001762507-26-000004
Jun 30, 20268-K0001517022-26-000047
Jun 29, 20261440001517022-26-000044
Jun 22, 202640001248144-26-000001
Jun 22, 202640001890219-26-000001
Jun 22, 202640001808317-26-000001
Jun 22, 202640001244159-26-000001
Jun 22, 20268-K0001517022-26-000043
Jun 22, 202640001609480-26-000003
Jun 22, 202640001204946-26-000001
May 12, 2026SCHEDULE 13G0000093751-26-000200
May 7, 20268-K0001517022-26-000038
May 7, 202610-Q0001517022-26-000039
Apr 29, 2026ARS0001140361-26-017532
Apr 28, 2026DEF 14A0001517022-26-000034
Apr 28, 2026DEFA14A0001517022-26-000035
Apr 15, 2026PRE 14A0001517022-26-000029
Apr 3, 202640001635046-26-000005
Apr 3, 202630001635046-26-000004
Apr 1, 20268-K0001517022-26-000024
Mar 26, 2026SCHEDULE 13G/A0000102909-26-000566